Osteosarcoma Prognosis: High RPS28 expression correlates with poor survival in osteosarcoma. Silencing RPS28 inhibits tumor proliferation, migration, and invasion in vitro and in vivo .
Pancreatic Cancer: RPS28 is detectable in pancreatic adenocarcinoma tissues via IHC, suggesting diagnostic utility .
Poxvirus Replication: RPS28 phosphorylation during poxvirus infection modulates ribosome function, enhancing viral spread .
MHC-I Antigen Presentation: RPS28 knockdown increases peptide supply for MHC-I loading by altering ribosomal activity and promoting non-canonical translation .
tsRNA Regulation: The LeuCAG3′tsRNA enhances RPS28 translation by binding its mRNA, maintaining 18S rRNA processing and 40S subunit biogenesis .
Cell Line Effects: RPS28 depletion in HEK-293T and osteosarcoma cells reduces ribosomal subunit assembly, leading to apoptosis .
Pathway Modulation:
Western Blot: Distinct 8 kDa band observed in human (HeLa, HEK-293T) and mouse (NIH/3T3) cell lines .
Immunoprecipitation: Efficient pull-down of RPS28 from HEK-293T lysates, with no cross-reactivity to control IgG .
IHC Optimization: Antigen retrieval with TE buffer (pH 9.0) recommended for human tissues .
Diamond-Blackfan Anemia (DBA): Mutations in RPS28 are linked to DBA15, a ribosomopathy characterized by bone marrow failure and congenital anomalies .
Therapeutic Target: RPS28’s role in ribosome biogenesis and cancer progression positions it as a potential target for small-molecule inhibitors or RNA-based therapies .
RPS28 (ribosomal protein S28) is a crucial component of the 40S ribosomal subunit. It belongs to the S28E family of ribosomal proteins and is located in the cytoplasm. Most significantly, RPS28 is essential for the biogenesis of 18S rRNA and proper ribosome assembly . Structurally, it's positioned at the mRNA exit channel near RACK1 on the ribosome, making it strategically important for translation processes . With a predicted protein size of approximately 8 kDa, this small protein plays disproportionately large roles in protein synthesis and cellular viability . Understanding RPS28 function is particularly important as its dysregulation has been implicated in certain cancer models, including hepatocellular carcinoma .
Based on available data, RPS28 antibodies have demonstrated effectiveness in several key experimental applications:
When selecting an RPS28 antibody, verify that it has been validated for your specific application and species of interest, as reactivity may vary between products .
Optimizing Western blot protocols for RPS28 detection requires careful consideration of several factors:
Sample preparation: Since RPS28 is a small protein (~8 kDa), use higher percentage (15-20%) SDS-PAGE gels to properly resolve the protein .
Transfer conditions: Consider semi-dry transfer with PVDF membranes for small proteins like RPS28.
Blocking: Use 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
Antibody dilution: Follow manufacturer-recommended dilutions; typically, commercially available RPS28 antibodies work well in the 1:500 to 1:2000 range .
Detection considerations: Be aware that post-translational modifications, particularly phosphorylation during conditions like viral infection, can cause band shifts in RPS28 on Western blots .
Controls: Include positive controls from tissues/cells known to express RPS28. Note that expression of HA-tagged RPS28 has been observed to downregulate endogenous RPS28, which could be leveraged as a control strategy .
Proper validation of an RPS28 antibody should include these essential steps:
Specificity testing: Verify single band detection at the expected molecular weight (~8 kDa) . Be aware that RPS28 can show band shifting due to phosphorylation under certain conditions, such as during poxvirus infection .
Knockdown/knockout controls: RNAi-mediated depletion of RPS28 has been successfully used to confirm antibody specificity .
Recombinant protein controls: If available, use purified RPS28 protein as a positive control.
Cross-reactivity assessment: Check for potential cross-reactivity with homologous ribosomal proteins.
Application-specific validation: Each intended application (WB, IHC, IF) should be separately validated.
Species reactivity: Confirm reactivity in your species of interest. Many commercial RPS28 antibodies show high homology across species, with some showing 100% immunogen sequence homology across multiple species including human, mouse, rat, and others .
Based on product information, RPS28 antibodies typically exhibit good stability when properly stored:
Working aliquots: To avoid repeated freeze-thaw cycles, create small working aliquots.
Stability period: Commercial preparations are generally stable for 12 months from the date of receipt when stored properly .
Buffer considerations: Most commercial preparations are supplied in PBS buffer with preservatives like 0.09% sodium azide and stabilizers like 2% sucrose .
Shipping conditions: Typically shipped on blue ice to maintain antibody integrity .
Formulation: Available as liquid preparations or lyophilized powder (particularly for shipping to certain regions like China) .
RPS28 undergoes important post-translational modifications that significantly impact ribosome function:
Phosphorylation sites: Mass spectrometry studies have identified RPS28 phosphorylation events that occur specifically during poxvirus infection, indicating potential virus-induced ribosome customization .
Functional impact: Phosphorylation of RPS28 during viral infection may contribute to customized ribosomes that preferentially translate viral mRNAs .
Detection challenges: Standard RPS28 antibodies may not show band shifts for phosphorylated RPS28 in Western blots, unlike other ribosomal proteins like RPS2 which display more obvious mobility shifts .
Methodological approach: To study phosphorylation of RPS28:
Perform LC-MS/MS analysis of ribosomes isolated from infected versus uninfected cells
Use phosphatase treatment of cell lysates to confirm modification status
Consider phospho-specific antibodies if phosphorylation sites are well-characterized
Research has shown that RPS28 phosphorylation appears to be virus-specific, occurring in poxvirus-infected cells but not in cells infected with other viruses like HSV-1 or VSV .
RPS28 plays a critical role in 18S rRNA processing, with several experimental approaches available to study this function:
Functional significance: RPS28 is essential for the biogenesis of 18S rRNA, and its depletion impairs 18S rRNA processing .
Downstream effects: Reduced RPS28 protein levels lead to decreased 18S rRNA, resulting in reduced 40S ribosomal subunit concentration and subsequent lowering of 80S monosomes .
Experimental approaches:
RNAi depletion: Knockdown of RPS28 via RNAi followed by analysis of 18S rRNA processing intermediates
Sucrose gradient fractionation: To analyze polysome profiles and detect changes in ribosome subunit abundance
Real-time PCR: To quantify rRNA levels after RPS28 manipulation
Northern blotting: To detect specific processing intermediates
Antibody-based detection: Using RPS28 antibodies to correlate protein levels with rRNA processing efficiency
Research shows that inhibition of LeuCAG3′tsRNA (which regulates RPS28) reduces 18S rRNA processing and lowers the number of 40S ribosomal subunits, confirming RPS28's importance in this pathway .
RPS28 expression is intricately regulated by tRNA-derived small RNAs through a fascinating post-transcriptional mechanism:
Key regulator: LeuCAG3′tsRNA (a tRNA-derived small RNA) specifically regulates RPS28 mRNA translation without affecting its transcription .
Mechanism: LeuCAG3′tsRNA binds to two target sites in human RPS28 mRNA, modulating its translation at a post-initiation stage .
Conservation: This regulatory mechanism is conserved between mouse and human, though with some differences in target sites. Target site A in the coding sequence is almost identical between species, while target B in the 3'UTR differs .
Experimental approaches:
ASO-mediated inhibition: Using antisense oligonucleotides to block LeuCAG3′tsRNA function
Mutagenesis: Constructing expression plasmids with mutations in potential LeuCAG3′tsRNA target sites
Sucrose gradient fractionation: To analyze polysomal distribution of RPS28 mRNA
Western blot analysis: To quantify RPS28 protein levels following manipulation of LeuCAG3′tsRNA
Real-time PCR: To confirm mRNA levels remain unchanged despite protein level alterations
Research demonstrates that inhibition of LeuCAG3′tsRNA reduces RPS28 protein without changing mRNA levels, confirming translational regulation. This ultimately affects 18S rRNA processing and can lead to reduced cell viability in cancer models .
RPS28 has emerged as an important factor in viral infection processes, particularly for poxviruses:
Viral customization: Poxviruses specifically modify host ribosomes, including phosphorylation of RPS28, suggesting ribosome customization for viral advantage .
Functional significance: RNAi-mediated depletion of RPS28 suppresses the spread of Vaccinia virus (VacV) in cell culture, indicating its importance for viral replication .
Viral specificity: RPS28 phosphorylation is detected specifically during poxvirus infection but not during infection with other viruses like HSV-1 or VSV .
Position-based importance: RPS28's location at the mRNA exit channel near RACK1 on the ribosome may explain its strategic importance during viral infection .
Experimental approaches:
RNAi depletion: To assess the effect of RPS28 knockdown on viral replication
LC-MS/MS analysis: To detect phosphorylation events on RPS28 during infection
Western blot: To detect potential band shifts indicating post-translational modifications
Viral protein expression analysis: To correlate RPS28 status with viral protein production
Interestingly, while RPS28 depletion suppresses viral spread, it does not induce cellular stress markers such as eIF2α phosphorylation or elevated expression of protein kinase R or interferon-stimulated genes .
RPS28 antibodies are finding important applications in cancer research due to the protein's connection to critical cellular processes:
Cancer relevance: Inhibition of LeuCAG3′tsRNA (which regulates RPS28) leads to apoptosis in human cancer cells and shows effects in orthotopic hepatocellular carcinoma (HCC) patient-derived xenograft models .
Mechanism of action: Decreased RPS28 protein (via LeuCAG3′tsRNA inhibition) impairs 18S rRNA processing, ultimately reducing cancer cell viability .
Methodological approaches:
Tissue microarray analysis: For evaluating RPS28 expression across tumor samples
Patient-derived xenograft models: To assess RPS28 targeting in vivo
Cell viability assays: Following RPS28 manipulation to assess cancer cell dependency
Combination with mass spectrometry: For integrated topological analysis in cancer research
Immunohistochemistry: To evaluate RPS28 expression patterns in different cancer types
Technical considerations:
Ensure antibody specificity in the cancer tissue type being studied
Consider the effects of potential RPS28 post-translational modifications in cancer contexts
Include appropriate positive and negative controls from relevant cancer and normal tissues
When analyzing proteomic data, be aware of potential limitations related to incomplete proteome coverage and poor consistency across samples
Research suggests that targeting the RPS28 regulatory pathway may represent a potential therapeutic approach for certain cancers, particularly hepatocellular carcinoma .